Peripheral T‐cell lymphoma

James Olen Armitage, J. P. Greer, A. M. Levine, D. D. Weisenburger, S. C. Formenti, M. Bast, S. Conley, J. Pierson, J. Linder, J. B. Cousar, B. N. Nathwani

Research output: Contribution to journalArticle

98 Citations (Scopus)

Abstract

Peripheral T‐cell lymphoma is the most common type of T‐cell lymphoma seen in adults in the United States. Clinical data were reviewed from 134 cases of peripheral T‐cell lymphoma diagnosed in three centers. The median age of the patients was 57 years (range, 4‐97 years), 59% were male, and 36 patients (27%) had a history of a preceding disorder of the immune system. The tumors were grouped histologically into large cell (43%), mixed large and small cell (40%), and small cell (17%). The stage at diagnosis was I (7%), II (21%), III (22%), and IV (50%). B symptoms were present in 57%. The most frequent sites of extranodal involvement were bone marrow (35%), skin (13%), and lung (11%). Eighty patients were treated with a multiagent chemotherapy regimen with proven curative potential in aggressive non‐Hodgkin's lymphomas and the remainder of the patients received less intensive chemotherapy (36 patients), radiotherapy (nine patients), or no treatment (nine patients). Fifty percent of the intensively treated patients achieved complete remission and the actuarial 4‐year survival was 45%. However, the 4‐year, disease‐free survival in patients with Stage IV disease was only 10%. Although peripheral T‐cell lymphomas appeared similar in many ways to their B‐cell counterparts, disease‐free survival by stage was low and patients with Stage IV disease had an especially poor outlook.

Original languageEnglish (US)
Pages (from-to)158-163
Number of pages6
JournalCancer
Volume63
Issue number1
DOIs
StatePublished - Jan 1 1989

Fingerprint

Lymphoma
Survival
Drug Therapy
Non-Hodgkin's Lymphoma
Immune System
Radiotherapy
Bone Marrow
Lung
Skin

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Armitage, J. O., Greer, J. P., Levine, A. M., Weisenburger, D. D., Formenti, S. C., Bast, M., ... Nathwani, B. N. (1989). Peripheral T‐cell lymphoma. Cancer, 63(1), 158-163. https://doi.org/10.1002/1097-0142(19890101)63:1<158::AID-CNCR2820630125>3.0.CO;2-B

Peripheral T‐cell lymphoma. / Armitage, James Olen; Greer, J. P.; Levine, A. M.; Weisenburger, D. D.; Formenti, S. C.; Bast, M.; Conley, S.; Pierson, J.; Linder, J.; Cousar, J. B.; Nathwani, B. N.

In: Cancer, Vol. 63, No. 1, 01.01.1989, p. 158-163.

Research output: Contribution to journalArticle

Armitage, JO, Greer, JP, Levine, AM, Weisenburger, DD, Formenti, SC, Bast, M, Conley, S, Pierson, J, Linder, J, Cousar, JB & Nathwani, BN 1989, 'Peripheral T‐cell lymphoma', Cancer, vol. 63, no. 1, pp. 158-163. https://doi.org/10.1002/1097-0142(19890101)63:1<158::AID-CNCR2820630125>3.0.CO;2-B
Armitage JO, Greer JP, Levine AM, Weisenburger DD, Formenti SC, Bast M et al. Peripheral T‐cell lymphoma. Cancer. 1989 Jan 1;63(1):158-163. https://doi.org/10.1002/1097-0142(19890101)63:1<158::AID-CNCR2820630125>3.0.CO;2-B
Armitage, James Olen ; Greer, J. P. ; Levine, A. M. ; Weisenburger, D. D. ; Formenti, S. C. ; Bast, M. ; Conley, S. ; Pierson, J. ; Linder, J. ; Cousar, J. B. ; Nathwani, B. N. / Peripheral T‐cell lymphoma. In: Cancer. 1989 ; Vol. 63, No. 1. pp. 158-163.
@article{29d396972bdb4eccacc092c339e82453,
title = "Peripheral T‐cell lymphoma",
abstract = "Peripheral T‐cell lymphoma is the most common type of T‐cell lymphoma seen in adults in the United States. Clinical data were reviewed from 134 cases of peripheral T‐cell lymphoma diagnosed in three centers. The median age of the patients was 57 years (range, 4‐97 years), 59{\%} were male, and 36 patients (27{\%}) had a history of a preceding disorder of the immune system. The tumors were grouped histologically into large cell (43{\%}), mixed large and small cell (40{\%}), and small cell (17{\%}). The stage at diagnosis was I (7{\%}), II (21{\%}), III (22{\%}), and IV (50{\%}). B symptoms were present in 57{\%}. The most frequent sites of extranodal involvement were bone marrow (35{\%}), skin (13{\%}), and lung (11{\%}). Eighty patients were treated with a multiagent chemotherapy regimen with proven curative potential in aggressive non‐Hodgkin's lymphomas and the remainder of the patients received less intensive chemotherapy (36 patients), radiotherapy (nine patients), or no treatment (nine patients). Fifty percent of the intensively treated patients achieved complete remission and the actuarial 4‐year survival was 45{\%}. However, the 4‐year, disease‐free survival in patients with Stage IV disease was only 10{\%}. Although peripheral T‐cell lymphomas appeared similar in many ways to their B‐cell counterparts, disease‐free survival by stage was low and patients with Stage IV disease had an especially poor outlook.",
author = "Armitage, {James Olen} and Greer, {J. P.} and Levine, {A. M.} and Weisenburger, {D. D.} and Formenti, {S. C.} and M. Bast and S. Conley and J. Pierson and J. Linder and Cousar, {J. B.} and Nathwani, {B. N.}",
year = "1989",
month = "1",
day = "1",
doi = "10.1002/1097-0142(19890101)63:1<158::AID-CNCR2820630125>3.0.CO;2-B",
language = "English (US)",
volume = "63",
pages = "158--163",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Peripheral T‐cell lymphoma

AU - Armitage, James Olen

AU - Greer, J. P.

AU - Levine, A. M.

AU - Weisenburger, D. D.

AU - Formenti, S. C.

AU - Bast, M.

AU - Conley, S.

AU - Pierson, J.

AU - Linder, J.

AU - Cousar, J. B.

AU - Nathwani, B. N.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - Peripheral T‐cell lymphoma is the most common type of T‐cell lymphoma seen in adults in the United States. Clinical data were reviewed from 134 cases of peripheral T‐cell lymphoma diagnosed in three centers. The median age of the patients was 57 years (range, 4‐97 years), 59% were male, and 36 patients (27%) had a history of a preceding disorder of the immune system. The tumors were grouped histologically into large cell (43%), mixed large and small cell (40%), and small cell (17%). The stage at diagnosis was I (7%), II (21%), III (22%), and IV (50%). B symptoms were present in 57%. The most frequent sites of extranodal involvement were bone marrow (35%), skin (13%), and lung (11%). Eighty patients were treated with a multiagent chemotherapy regimen with proven curative potential in aggressive non‐Hodgkin's lymphomas and the remainder of the patients received less intensive chemotherapy (36 patients), radiotherapy (nine patients), or no treatment (nine patients). Fifty percent of the intensively treated patients achieved complete remission and the actuarial 4‐year survival was 45%. However, the 4‐year, disease‐free survival in patients with Stage IV disease was only 10%. Although peripheral T‐cell lymphomas appeared similar in many ways to their B‐cell counterparts, disease‐free survival by stage was low and patients with Stage IV disease had an especially poor outlook.

AB - Peripheral T‐cell lymphoma is the most common type of T‐cell lymphoma seen in adults in the United States. Clinical data were reviewed from 134 cases of peripheral T‐cell lymphoma diagnosed in three centers. The median age of the patients was 57 years (range, 4‐97 years), 59% were male, and 36 patients (27%) had a history of a preceding disorder of the immune system. The tumors were grouped histologically into large cell (43%), mixed large and small cell (40%), and small cell (17%). The stage at diagnosis was I (7%), II (21%), III (22%), and IV (50%). B symptoms were present in 57%. The most frequent sites of extranodal involvement were bone marrow (35%), skin (13%), and lung (11%). Eighty patients were treated with a multiagent chemotherapy regimen with proven curative potential in aggressive non‐Hodgkin's lymphomas and the remainder of the patients received less intensive chemotherapy (36 patients), radiotherapy (nine patients), or no treatment (nine patients). Fifty percent of the intensively treated patients achieved complete remission and the actuarial 4‐year survival was 45%. However, the 4‐year, disease‐free survival in patients with Stage IV disease was only 10%. Although peripheral T‐cell lymphomas appeared similar in many ways to their B‐cell counterparts, disease‐free survival by stage was low and patients with Stage IV disease had an especially poor outlook.

UR - http://www.scopus.com/inward/record.url?scp=0024507182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024507182&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19890101)63:1<158::AID-CNCR2820630125>3.0.CO;2-B

DO - 10.1002/1097-0142(19890101)63:1<158::AID-CNCR2820630125>3.0.CO;2-B

M3 - Article

C2 - 2783376

AN - SCOPUS:0024507182

VL - 63

SP - 158

EP - 163

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 1

ER -